Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for J2374. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
10
Median % of Medicare
--
Rate range
$1.39 - $79.03
J2374 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arizona | $74.00 | -- | -- | 2026 |
| California | $50.31 | -- | -- | 2026 |
| Kansas | $27.73 | -- | -- | 2026 |
| Minnesota | $27.72 | -- | Required | 2026 |
| Mississippi | $50.87 | -- | -- | 2026 |
| Nebraska | $79.03 | -- | -- | 2026 |
| New Hampshire | $74.00 | -- | Not required | 2026 |
| Oklahoma | $1.39 | -- | -- | 2026 |
| Utah | $13.31* | -- | Required | 2026 |
| Wisconsin | $66.55 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related drugs codes
- J0013 - Esketamine, nasal spray, 1 mg
- J0120 - Injection, tetracycline, up to 250 mg
- J0121 - Injection, omadacycline, 1 mg
- J0122 - Injection, eravacycline, 1 mg
- J0129 - Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130 - Injection abciximab, 10 mg
- J0131 - Injection, acetaminophen, not otherwise specified,10 mg
- J0132 - Injection, acetylcysteine, 100 mg
All 157 codes from J2002 to J2998 or every drugs code by number.
Frequently asked questions
How much does Medicaid pay for J2374?
10 state Medicaid programs publish a fee-for-service rate for J2374 (apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml), ranging from $1.39 in Oklahoma to $79.03 in Nebraska. The full table on this page lists every publishing state's current rate.
Which state pays the most for J2374?
Nebraska publishes the highest Medicaid rate for J2374 at $79.03. Oklahoma publishes the lowest at $1.39.
Does J2374 require prior authorization under Medicaid?
2 of the 10 publishing states flag J2374 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".